ARUP Applauds Federal Court Decision Vacating the FDA’s Final Rule Regulating Lab-Developed Tests
The rule and its compliance deadlines are no longer in effect, benefiting patient care, innovation, and the greater laboratory community, ARUP leaders said.- March 31, 2025
- March 11, 2025Pramana, Inc., and ARUP are collaborating to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology.
- March 6, 2025
ARUP Laboratories Expands AI-Augmented Parasitology Screening Tool, Improves Detection and Diagnosis
ARUP will expand its AI-augmented screening tool for the detection of human gastrointestinal parasites to become first and only lab to apply AI to the entire ova and parasite testing process. - February 3, 2025The partnership combines Tasso’s clinical grade blood collection solutions and ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research.
- January 3, 2025ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1).
- October 21, 2024
Augurex Announces Agreement With ARUP To Expand Access to Advanced Rheumatoid Arthritis Diagnosis
ARUP Laboratories is partnering with Augurex Life Sciences Corp. to include the 14-3-3η test in the ARUP test menu to enhance the early detection of rheumatoid arthritis. - September 13, 2024ARUP has been awarded a CDC contract for avian influenza A (H5N1) test development, which recognizes our expertise and experience with assay development and our desire to serve public health needs.
- July 30, 2024
New ARUP Laboratories’ Grant Will Fund Innovative Research to Advance Laboratory Medicine
The new Sherrie Perkins Research and Innovation Collaboration Grant, designed to foster collaboration in healthcare, will fund cutting-edge research in lab medicine that could impact patient care. - May 30, 2024
ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests
ARUP’s declaration amplifies the lawsuit’s claims that the FDA does not have legal authority over laboratory testing services and that regulating these services is unreasonable. - April 29, 2024
ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs. - April 24, 2024
ARUP Partners With ELLKAY to Bring Connectivity Solutions to Health System Outreach Operations
A new partnership between ARUP and connectivity provider ELLKAY aims to give health systems the testing support, guidance, and technology needed to establish or expand lab outreach operations. - April 1, 2024
New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health
Dan Albertson, MD, will serve as president of the new University Business Unit and become a member of ARUP’s executive committee. Albertson said service to patients and colleagues will be his focus.